Cannabis Use Disorder Market Report 2026

Cannabis Use Disorder Market Overview

• Cannabis Use Disorder market size has reached to $1.65 billion in 2025 • Expected to grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Rising Awareness And Diagnosis Of Cannabis Addiction Driving The Market Growth • Market Trend: Advanced And Personalized Treatment Options For Cannabis Use Disorder • North America was the largest region in 2025.

What Is Covered Under Cannabis Use Disorder Market?

Cannabis use disorder (CUD) refers to a condition characterized by the problematic or excessive use of cannabis, leading to significant impairment or distress. It is classified as a type of substance use disorder and occurs when an individual is unable to control or reduce their cannabis consumption despite negative consequences. The main types of treatment for cannabis use disorder are pharmacotherapy and behavioral therapies. Pharmacotherapy for cannabis use disorder (CUD) involves medications to ease withdrawal, curb cravings, and aid recovery. It is administered through various routes of administration, such as oral, transdermal, inhalation, and sublingual, and is used by several end-users, including hospitals, specialty clinics, rehabilitation centers, and homecare settings.

What Is The Cannabis Use Disorder Market Growth Forecast?

The cannabis use disorder market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing acceptance of digital mental health solutions, rising investments in addiction research, expansion of telehealth-based treatment models, growing focus on outcome-based care, increasing integration of pharmacotherapy and behavioral therapy. Major trends in the forecast period include increasing adoption of integrated behavioral and pharmacological treatments, rising focus on personalized addiction therapy programs, growing use of digital therapeutics and remote monitoring, expansion of multidisciplinary treatment approaches, enhanced emphasis on early diagnosis and intervention.

Global Cannabis Use Disorder Market Segmentation

1) By Treatment: Pharmacotherapy, Behavioral Therapies 2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual 3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers Subsegments: 1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Anxiolytics (Non-Benzodiazepine), Antipsychotics 2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy

What Is The Driver Of The Cannabis Use Disorder Market?

The increasing awareness and diagnosis of cannabis addiction is expected to propel the growth of the cannabis use disorder market going forward. Awareness and diagnosis of cannabis addiction involve educating the public, healthcare professionals, and individuals about the signs, symptoms, and risks of cannabis use disorder (CUD). Increasing awareness and diagnosis of cannabis addiction rise due to several factors, such as increased cannabis legalization & availability and growing scientific & medical recognition. Cannabis use disorder treatment offers a structured approach to managing withdrawal symptoms, reducing cravings, and addressing underlying psychological factors, directly supports the diagnosis of cannabis addiction by providing clinical evidence of dependency patterns, reinforcing the severity of the disorder, and guiding the appropriate level of intervention based on the individual's specific needs. For instance, in November 2024, according to the The Office for Health Improvement and Disparities, a UK-based government agency, the share of new entrants seeking treatment for cannabis-related issues remained relatively stable this year, rising slightly by 0.5 percentage points from 20.9% to 21.4%. Meanwhile, the number of new entrants with benzodiazepine-related problems grew from 3,620 in 2022–2023 to 3,872 this year. Therefore, increasing awareness and diagnosis of cannabis addiction is driving the growth of the cannabis use disorder industry.

Key Players In The Global Cannabis Use Disorder Market

Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam's Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone

Global Cannabis Use Disorder Market Trends and Insights

Major companies operating in the cannabis use disorder (CUD) market are focusing on developing advanced solutions, such as digital therapeutics and technology-enabled behavioral intervention platforms, to help individuals reduce or stop problematic cannabis use through structured counseling, personalized care pathways, and ongoing support. Digital therapeutics in CUD treatment refer to clinically validated, technology-driven programs that deliver behavioral therapies, track progress, and provide remote access to licensed clinicians to improve adherence and long-term recovery outcomes. For instance, in April 2024, Pelago, a US-based virtual clinic specializing in substance use management, introduced a cannabis use disorder (CUD) treatment program designed to address the growing number of individuals affected by the condition estimated at nearly 18 million adults in the U.S. Pelago’s program offers education on cannabis use and provides evidence-based therapies such as cognitive behavioral therapy and motivational enhancement therapy, while also extending support to adolescents aged 15-17 years through abstinence-focused treatment goals.

What Are Latest Mergers And Acquisitions In The Cannabis Use Disorder Market?

In January 2025, Lantern, a US-based specialty care platform, partnered with Pelago to expand access to substance use disorder treatment. The partnership aims to simplify healthcare benefits for Lantern's employers and provide more people with access to substance use disorder support. Pelago is a US-based digital clinic that provides a cannabis use disorder treatment solution.

Regional Outlook

North America was the largest region in the cannabis use disorder market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cannabis Use Disorder Market?

The cannabis use disorder market consists of revenues earned by entities by providing services such as inpatient and outpatient treatment programs, behavioral therapies, digital health solutions and education programs, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cannabis use disorder market also includes sales of diagnostic tools and pharmaceutical products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cannabis Use Disorder Market Report 2026?

The cannabis use disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis use disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.